Skip to main content

Health & Medicine

Jazz wins FDA nod for cancer therapy developed with BeOne, Zymeworks

seekingalpha.com ·1h ago

We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma financialpost.com
FDA approves Jazz's Ziihera in frontline gastric cancer endpoints.news
FDA approves Tevimbra combo for HER2+ gastric cancer treatment investing.com

Read the original at seekingalpha.com →

More in Health & Medicine

DHS Auditors Rebuke ICE for Fentanyl Failures During Mass Deportation

ICE's fentanyl work plummeted as immigration enforcement surged under Trump's mass deportation push, the DHS watchdog said.

1h ago ·newsweek.com

FDA approves Tevimbra combo for HER2+ gastric cancer treatment

1h ago ·investing.com

J&J’s Imaavy wins label expansion; Two approvals in Japan

J&J’s Imaavy wins label expansion: The monoclonal antibody is now the first treatment approved specifically for warm autoimmune hemolytic anemia, a rare autoantibody disease that causes severe anemia…

1h ago ·endpoints.news

Spain to send 45,000 vaccines to Ceuta to prevent spread of diseases among migrant population

VACCINES will be available to both migrants and Ceuta residents, with authorities stressing there is no public-health emergency in the enclave.

1h ago ·theolivepress.es

'This cannot happen again' - Friedreich's Ataxia patients

Patients with Friedreich's Ataxia have called for change after their campaign for the reimbursement of the drug Skyclarys.

1h ago ·rte.ie

STAT+: How Trump’s funding cuts are reshaping the health system

STAT examines Republicans’ health care funding cuts, mRNA science defeats politics, and Medicaid tries out a new way to deny drug coverage.

1h ago ·statnews.com

More from Tuesday 25 August →